INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
Scope & Guideline
Fostering Knowledge in the Evolving Landscape of Immunology.
Introduction
Aims and Scopes
- Clinical and Experimental Allergy Research:
The journal publishes studies that explore the mechanisms underlying allergic diseases, including asthma, rhinitis, and food allergies, utilizing both clinical trials and experimental models. - Immunotherapy and Treatment Approaches:
A significant focus is on the efficacy and safety of immunotherapy techniques, including subcutaneous and sublingual routes, in treating various allergic conditions. - Epidemiology and Public Health:
The journal addresses the prevalence, risk factors, and public health implications of allergic diseases across diverse populations, contributing to a better understanding of environmental and genetic influences. - Innovative Diagnostic Techniques:
Research on novel diagnostic methods, including component-resolved diagnostics and molecular allergy testing, is a key area, aimed at improving accuracy in allergy diagnosis. - Molecular and Cellular Mechanisms:
Studies investigating the cellular and molecular pathways involved in immune responses and allergic reactions, including cytokine profiles, T cell differentiation, and the role of microbiota. - Emerging Allergens and Sensitization Patterns:
The journal also emphasizes research on newly identified allergens and changing patterns of sensitization, particularly in the context of global environmental changes.
Trending and Emerging
- Impact of COVID-19 on Allergic Conditions:
Research exploring the effects of the COVID-19 pandemic on the prevalence and management of allergic diseases has surged, highlighting the need for understanding how respiratory viral infections influence allergic responses. - Biologic Therapies and Their Applications:
There is a growing body of literature focusing on the use of biologic therapies for severe allergic conditions, such as chronic urticaria and eosinophilic asthma, indicating a shift towards targeted treatments. - Microbiome Research in Allergy:
Emerging studies are increasingly investigating the role of the microbiome in the development and exacerbation of allergic diseases, suggesting new avenues for prevention and treatment. - Artificial Intelligence and Machine Learning in Allergy Diagnosis:
The integration of AI and machine learning in predicting allergic responses and optimizing treatment protocols is becoming a prominent theme, reflecting technological advancements in the field. - Environmental Influences on Allergy Development:
Research is expanding to include the effects of climate change, urbanization, and dietary shifts on the prevalence of allergic diseases, indicating a holistic approach to understanding allergies. - Personalized Medicine in Allergy Treatment:
A trend towards personalized approaches in the management of allergic diseases is evident, with studies focusing on genetic and immunological markers that predict responses to specific therapies.
Declining or Waning
- Traditional Allergen Testing Methods:
There has been a noticeable decline in studies focusing on conventional skin prick testing and serological methods, as newer, more precise diagnostic techniques gain traction. - Single-Factor Allergy Studies:
Research centered around isolated allergens without considering poly-sensitization or environmental interactions seems to be diminishing, as the complexity of allergic diseases is increasingly recognized. - Generalized Treatment Protocols:
Studies advocating for one-size-fits-all treatment approaches, particularly in immunotherapy, are less frequent as personalized medicine becomes more prominent. - Basic Immunology without Clinical Application:
Research focused solely on basic immunological concepts without direct clinical applications or implications is declining, in favor of studies that bridge laboratory findings with clinical practice. - Non-Evidence-Based Dietary Interventions:
There is a waning interest in dietary approaches for allergy management that lack robust evidence or clinical validation, as the focus shifts to more scientifically grounded interventions.
Similar Journals
Current Opinion in Allergy and Clinical Immunology
Bridging research and clinical excellence in allergy care.Current Opinion in Allergy and Clinical Immunology, published by Lippincott Williams & Wilkins, is a pivotal journal that serves as a key resource for professionals in the fields of immunology and allergy. With an ISSN of 1528-4050 and an E-ISSN of 1473-6322, this journal presents cutting-edge reviews of the latest research findings, methodologies, and therapeutic approaches in the management of allergic and immunological disorders. With a Q3 category ranking in both Immunology and Allergy for 2023, and a Scopus rank of #103 in Immunology and Allergy, it reflects a solid position within the scientific community. Operating in the highly dynamic fields of immunology and clinical practice since its inception in 2001, the journal aims to harmonize emerging research trends with clinical applications to enhance patient outcomes. Although it does not currently offer Open Access options, the journal's substantial impact factor attests to its significance as a scholarly resource. By disseminating high-quality reviews and expert opinions, Current Opinion in Allergy and Clinical Immunology continues to foster knowledge advancement and professional development among researchers, practitioners, and students alike.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Shaping the future of allergy research and patient care.JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, published by MOSBY-ELSEVIER, stands as a leading peer-reviewed journal dedicated to advancing the understanding of allergies and immunological conditions. With a notable impact factor and a prominent stature in the academic community, it ranks in the Q1 category for both Immunology and Allergy in 2023, reflecting its significance and high citation rates among researchers. Since its establishment in 1963, the journal has fostered scientific discourse and innovation in the field, positioning itself as an essential resource for both seasoned professionals and emerging scholars. The Scopus rankings underscore its influence, being ranked 12th out of 233 in Immunology and Allergy and 15th out of 236 in Immunology and Microbiology, placing it in the top centile of both categories. The journal aims to disseminate cutting-edge research, reviews, and clinical studies that deepen our understanding of allergic diseases and enhance patient care. While not an open access journal, it provides institutions and individuals with opportunities to stay informed on crucial advancements in the immunological sciences.
ALLERGOLOGIA ET IMMUNOPATHOLOGIA
Pioneering Research in Immunology and Allergy for a Healthier FutureALLERGOLOGIA ET IMMUNOPATHOLOGIA is a distinguished academic journal dedicated to the field of immunology and allergy, published by CODON PUBLICATIONS, based in Singapore. With its ISSN 0301-0546 and E-ISSN 1578-1267, this journal aims to provide an open platform for researchers and practitioners to share their findings, emphasizing topics related to immunopathology and respiratory health. Covering a broad scope from 1973 to 2024, it currently holds a notable position in several category quartiles, including Q3 in Immunology and Allergy, and Q3 in Pulmonary and Respiratory Medicine as of 2023. Despite the absence of an open access option, the journal maintains an essential role in disseminating pivotal research, reflected in its Scopus rankings that position it within the core of its discipline. With an impact factor acknowledging the significance of its contributions, ALLERGOLOGIA ET IMMUNOPATHOLOGIA continues to be a vital resource for ongoing education and advancement in immunological and allergic research.
Allergy Asthma & Immunology Research
Transforming findings into clinical excellence.Allergy Asthma & Immunology Research, published by the Korean Academy of Asthma Allergy & Clinical Immunology, is a leading journal dedicated to advancing the fields of immunology, allergy, and respiratory medicine. With an ISSN of 2092-7355 and an E-ISSN of 2092-7363, this esteemed publication has been a cornerstone for researchers and practitioners since its inception in 2009 and continues to disseminate critical findings through till 2024. The journal is ranked in the Q3 category in Immunology and the Q2 category in Immunology and Allergy as well as Pulmonary and Respiratory Medicine, illustrating its impact in these vital fields. With a solid Scopus ranking in multiple sub-disciplines, the journal not only contributes to the scientific discourse but also promotes innovative research and clinical practices. Although currently operating without an open access model, the journal remains highly regarded for its thorough peer-review process and commitment to academic excellence, making it an essential resource for professionals, researchers, and students passionate about advancing knowledge in allergy, asthma, and immunology.
ALLERGY AND ASTHMA PROCEEDINGS
Exploring breakthroughs in respiratory health.ALLERGY AND ASTHMA PROCEEDINGS, published by Ocean Side Publications Inc, is a vital resource in the fields of Immunology, Allergy, and Pulmonary Medicine. With an impressive trajectory of publication from 1996 to 2024, this journal serves as a platform for cutting-edge research and advancements in the understanding of allergic and asthmatic conditions. Positioned in the Q3 quartile for Immunology and Allergy and Q2 for both Medicine (miscellaneous) and Pulmonary Medicine, the journal exhibits a robust impact within the academic community, boasting Scopus rankings that reflect its significance. The journal offers open access options, allowing for the dissemination of critical findings to a wider audience. Aimed at researchers, healthcare professionals, and students alike, ALLERGY AND ASTHMA PROCEEDINGS addresses the complexities of respiratory diseases and facilitates the sharing of knowledge that is essential to improving patient care and outcomes.
ALLERGOLOGIE
Cultivating a Community of Allergy ExpertsALLERGOLOGIE is a prominent academic journal dedicated to the field of immunology and allergy, published by DUSTRI-VERLAG DR KARL FEISTLE in Germany. Since its inception in 1978, the journal has provided a vital platform for researchers, clinicians, and students to disseminate their findings, share insights, and foster advancements in the understanding of allergic diseases and immunological responses. With an ISSN of 0344-5062 and an E-ISSN of the same number, it is a respected source within its category, currently ranked in the 2023 Q4 of the Scopus metrics in immunology and allergy, reflecting its commitment to quality and scholarly rigor. Although not fully open access, ALLERGOLOGIE makes significant contributions to the dialogue on allergy-related topics, encouraging engagement from its readership through a diverse array of articles that span from clinical trials to innovative research methods. This journal continues to be an essential resource for anyone involved in the pursuit of knowledge in allergy and immunology.
Postepy Dermatologii i Alergologii
Championing open access to vital health insights.Postepy Dermatologii i Alergologii is a distinguished Open Access journal published by TERMEDIA PUBLISHING HOUSE LTD, dedicated to advancing the fields of Dermatology and Immunology and Allergy. Since its inception in 2003, this journal has served as a vital platform for researchers and practitioners alike, promoting knowledge sharing and collaboration in Poland and beyond. With a current impact ranking placing it in the Q3 quartile for both Dermatology and Immunology and Allergy categories, it plays a significant role in contributing to academic discourse within these fields. The journal is indexed in Scopus, with respectable rankings reflecting its relevance and quality—#65/142 in Dermatology and #163/233 in Immunology and Allergy. Researchers are encouraged to explore a vast array of innovative studies and reviews, making it an essential resource for anyone seeking to stay at the forefront of dermatological and allergic research. For those interested in discovering groundbreaking findings and contributing to the ongoing dialogue in these disciplines, Postepy Dermatologii i Alergologii offers not only free accessibility but also a commitment to scholarly excellence.
AIMS Allergy and Immunology
Empowering Global Collaboration in Immunological ResearchAIMS Allergy and Immunology is a prestigious open access journal dedicated to advancing knowledge in the fields of allergy and immunology. Published by the American Institute of Mathematical Sciences (AIMS), this journal provides a vibrant platform for researchers, practitioners, and scholars to share groundbreaking findings and insights. Recognized for its commitment to disseminating high-quality research since its inception in 2017, AIMS Allergy and Immunology contributes significantly to the understanding of complex immunological mechanisms and allergic responses, thus playing a pivotal role in enhancing clinical practices and therapeutic strategies. With its ISSN 2575-615X, the journal aims to facilitate a robust exchange of ideas and promote collaboration within the scientific community. Researchers and practitioners are encouraged to access the latest studies and reviews, which are all freely available online, ensuring that vital information reaches a global audience without barriers. Together, we can tackle the challenges posed by allergies and immune disorders through rigorous scientific inquiry and innovation.
ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY
Connecting Asia-Pacific researchers for impactful discoveries.The ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, published by the Allergy Immunology Society of Thailand, is a pivotal platform for disseminating high-quality research in the fields of allergy and immunology. Established in 1983, this journal has consistently evolved to address the pressing challenges and advancements in these dynamic disciplines, contributing significantly to the global scientific community's understanding of immunological disorders. With a category ranking of Q3 in Immunology and Allergy, and Q2 in Medicine (miscellaneous) for 2023, the journal stands at the forefront of impactful research, engaging with a diverse audience of researchers, clinicians, and students alike. Although it operates on a non-open access model, its rigorous peer-review process ensures that published articles meet the highest academic standards. Located in Bangkok, Thailand, the journal connects researchers across the Asia-Pacific region, fostering collaboration and innovation to enhance patient care in the realm of allergy and immunology.
Allergo Journal
Exploring the frontiers of allergenic research.Welcome to the Allergo Journal, a pivotal publication in the field of Immunology and Allergy, housed under the esteemed SPRINGER HEIDELBERG publishing house. With an ISSN of 0941-8849 and E-ISSN 2195-6405, the journal has been serving the scientific community since its inception in 1994. Although its Scopus coverage was discontinued in 2017, the journal remains significant, ranked #135 out of 186 in its category and positioned in the 27th percentile, reflecting its contributions to vital research in allergy and immunological disorders. While the journal is not an open access publication, it continues to provide a platform for rigorous academic discourse and advances in the study of allergens and immune response. The Allergo Journal stands as a crucial resource for researchers, professionals, and students dedicated to deepening their understanding of allergies and immunology, fostering advancements in therapy and comprehensive patient care.